Taiwan · Delayed Price · Currency is TWD Lumosa Therapeutics Statistics
Total Valuation
TPEX:6535 has a market cap or net worth of TWD 32.77 billion. The enterprise value is 31.95 billion.
| Market Cap | 32.77B |
| Enterprise Value | 31.95B |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6535 has 168.46 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Current Share Class | 168.46M |
| Shares Outstanding | 168.46M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 6.83% |
| Float | 88.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 769.39 |
| PB Ratio | 20.45 |
| P/TBV Ratio | 20.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -73.71 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -76.25 |
Financial Position
The company has a current ratio of 7.91, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.91 |
| Quick Ratio | 6.74 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -1,958.18 |
Financial Efficiency
Return on equity (ROE) is -31.91% and return on invested capital (ROIC) is -18.12%.
| Return on Equity (ROE) | -31.91% |
| Return on Assets (ROA) | -16.30% |
| Return on Invested Capital (ROIC) | -18.12% |
| Return on Capital Employed (ROCE) | -25.27% |
| Revenue Per Employee | 990,395 |
| Profits Per Employee | -10.08M |
| Employee Count | 43 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.15% in the last 52 weeks. The beta is 0.11, so TPEX:6535's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -40.15% |
| 50-Day Moving Average | 240.89 |
| 200-Day Moving Average | 194.50 |
| Relative Strength Index (RSI) | 43.42 |
| Average Volume (20 Days) | 339,521 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6535 had revenue of TWD 42.59 million and -433.41 million in losses. Loss per share was -2.61.
| Revenue | 42.59M |
| Gross Profit | 23.06M |
| Operating Income | -405.34M |
| Pretax Income | -443.16M |
| Net Income | -433.41M |
| EBITDA | -401.01M |
| EBIT | -405.34M |
| Loss Per Share | -2.61 |
Balance Sheet
The company has 840.48 million in cash and 8.63 million in debt, giving a net cash position of 831.85 million or 4.94 per share.
| Cash & Cash Equivalents | 840.48M |
| Total Debt | 8.63M |
| Net Cash | 831.85M |
| Net Cash Per Share | 4.94 |
| Equity (Book Value) | 1.60B |
| Book Value Per Share | 9.45 |
| Working Capital | 887.34M |
Cash Flow
In the last 12 months, operating cash flow was -418.30 million and capital expenditures -668,000, giving a free cash flow of -418.97 million.
| Operating Cash Flow | -418.30M |
| Capital Expenditures | -668,000 |
| Free Cash Flow | -418.97M |
| FCF Per Share | -2.49 |
Margins
| Gross Margin | 54.16% |
| Operating Margin | -951.80% |
| Pretax Margin | -1,040.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6535 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | -1.32% |
| FCF Yield | -1.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6535 has an Altman Z-Score of 168.69 and a Piotroski F-Score of 3.
| Altman Z-Score | 168.69 |
| Piotroski F-Score | 3 |